The Venture Codex Logo

The Venture Codex

Institute for Follicular Lymphoma Innovation

1440 Bridgegate Dr, Diamond Bar, CA, 91765, United States

Overview

Institute focused on bio-molecular innovations for follicular lymphoma.

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

—

Geographic focus

France
Switzerland

Sector focus

—

Investment portfolio

2rounds
NAMEDATESIZE
ENTEROME
Jun 2025Led
$19 MOther Equity
Araris Biotech
Oct 2022Participated
$24 MOther Equity
ENTEROME
Jun 2025Led
$19 MOther Equity
Araris Biotech
Oct 2022Participated
$24 MOther Equity
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Institute for Follicular Lymphoma Innovation: 2 funding rounds are recorded in the selected participation categories.All available history.
Institute for Follicular Lymphoma Innovation: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Other Equity11

Monthly Deal Activity

Institute for Follicular Lymphoma Innovation: 2 deals are recorded across 49 months.All available history.
Institute for Follicular Lymphoma Innovation: 2 deals are recorded across 49 months. All available history
MonthDeals
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '251
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Institute for Follicular Lymphoma Innovation: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Institute for Follicular Lymphoma Innovation: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2

Deal Size Distribution

Institute for Follicular Lymphoma Innovation: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Institute for Follicular Lymphoma Innovation: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Institute for Follicular Lymphoma Innovation: Europe has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Institute for Follicular Lymphoma Innovation: Europe has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
Europe2
Institute for Follicular Lymphoma Innovation: 12 co-investors are shown, with 4BIO Capital sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Institute for Follicular Lymphoma Innovation: 12 co-investors are shown, with 4BIO Capital sharing 1 recorded deals. All available history
Co-investorShared deals
4BIO Capital1
btov Partners1
Lundbeckfonden BioCapital1
Primo Ventures1
Pureos Bioventures1
Redalpine1
Schroders Capital1
Seventure Partners1
SymBiosis1
The Leukemia & Lymphoma Society1
VI Partners1
Wille Finance1

Investment Strategy

Institute for Follicular Lymphoma Innovation: Led accounts for 50% and participating for 50% of round participation.All available history.
Institute for Follicular Lymphoma Innovation: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led150%
Participating150%
Institute for Follicular Lymphoma Innovation: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Institute for Follicular Lymphoma Innovation: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

No team members found for this fund.